In a variety of tumor mouse models, including antibody - resistant tumor models, the antibody - IFN therapy was more effective than
antibody therapy alone.
Not exact matches
To meet this end, CCIR members take advantage of resources offered by MD Anderson, including the CCSG Shared Resources, Immune Monitoring Core Laboratory and GMP Cell Facility, allowing them to follow the «bench - to - beside» approach to develop and improve cancer immunotherapy in the form of cellular
therapy, a vaccine or targeting
antibody, either
alone or in combination with conventional
therapies or newly developed
therapies.
Through long - established collaborations in Durban and Kimberley, these studies in particular seek to define: the immune responses that are effective in control of HIV infection; the impact of HLA - mediated selection pressure on HIV at the individual and population level; the mechanisms of HIV non-pathogenicity; the nature and consequences of ontogeny of the virus - specific immune response; and finally the prospects for interventions including antiretroviral
therapy,
alone or in combination with broadly neutralising
antibodies and / or T - cell vaccines, to achieve HIV eradication.